AKT1 and diabetes mellitus: Inhibited EGFR/PI3K/AKT signaling pathway, reduced the released of inflammatory factors IL-1β, IL-6, TNF-αImproved lipid and glucose metabolism, promoted adipogenesis, improved insulin sensitivity by regulating PI3K-Akt signaling pathway, and fight against diabetes and its complications.